Aurobindo Pharma Quarterly results
BSE:524804 | NSE:AUROPHARMAEQ | IND:Pharma - Indian | ISIN code:INE406A01037 | SECT:Pharmaceuticals
BSE
Change:
Volume:
Open:
Prv. Close:
Today:
52-Wk:
Bid:
()
Offer:
()
NSE
Change:
Volume:
Open:
Prv. Close:
Today:
52-Wk:
Bid:
()
Offer:
()
The Quarterly Results page of Aurobindo Pharma Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.
TOTAL INCOME
Rs2,525.41Cr.
PEER RANGE
EBIT
Rs497.37Cr.
PEER RANGE
PAT
Rs329.04Cr.
PEER RANGE
| Quarterly - Aurobindo Pharma Ltd. | |||||
Rs (in Crores) | |||||
| Jun'24 | Mar'24 | Dec'23 | Sep'23 | Jun'23 | |
| INCOME | |||||
| Net Sales Turnover | 2460.09 | 2894.03 | 2692.03 | 2668.76 | 2390.82 |
| Other Income | 65.32 | 122.97 | 331.13 | 67.08 | 94.88 |
| Total Income | 2525.41 | 3017.00 | 3023.16 | 2735.84 | 2485.70 |
| EXPENSES | |||||
| Stock Adjustments | -35.56 | -13.10 | -59.76 | -27.12 | -16.25 |
| Raw Material Consumed | 1318.18 | 1401.56 | 1465.93 | 1518.33 | 1375.26 |
| Power and Fuel | .00 | .00 | .00 | .00 | .00 |
| Employee Expenses | 259.33 | 248.91 | 248.08 | 247.51 | 236.06 |
| Administration and Selling Expenses | .00 | .00 | .00 | .00 | .00 |
| Research and Development Expenses | .00 | .00 | .00 | .00 | .00 |
| Expenses Capitalised | .00 | .00 | .00 | .00 | .00 |
| Other Expenses | 419.21 | 481.87 | 556.09 | 384.86 | 373.37 |
| Provisions Made | .00 | .00 | .00 | .00 | .00 |
| TOTAL EXPENSES | 1961.16 | 2119.24 | 2210.34 | 2123.58 | 1968.44 |
| Operating Profit | 498.93 | 774.79 | 481.69 | 545.18 | 422.38 |
| EBITDA | 564.25 | 897.76 | 812.82 | 612.26 | 517.26 |
| Depreciation | 66.88 | 64.81 | 64.35 | 65.79 | 59.63 |
| EBIT | 497.37 | 832.95 | 748.47 | 546.47 | 457.63 |
| Interest | 51.13 | 53.07 | 61.25 | 36.69 | 31.59 |
| EBT | 446.24 | 779.88 | 687.22 | 509.78 | 426.04 |
| Taxes | 117.20 | 201.21 | 63.44 | 130.13 | 90.09 |
| Profit and Loss for the Year | 329.04 | 578.67 | 623.78 | 379.65 | 335.95 |
| Extraordinary Items | .00 | .00 | .00 | .00 | .00 |
| Prior Year Adjustment | .00 | .00 | .00 | .00 | .00 |
| Other Adjustment | .00 | .00 | .00 | .00 | .00 |
| Reported PAT | 329.04 | 578.67 | 623.78 | 415.74 | 335.95 |
| KEY ITEMS | |||||
| Reserves Written Back | .00 | .00 | .00 | .00 | .00 |
| Equity Capital | 58.59 | 58.59 | 58.59 | 58.59 | 58.59 |
| Reserves and Surplus | .00 | .00 | .00 | .00 | .00 |
| Equity Dividend Rate | .00 | .00 | .00 | .00 | .00 |
| Agg. Non-Promoter Share(Lakhs) | .00 | .00 | .00 | .00 | .00 |
| Agg. Non-Promoter Holding(%) | .00 | .00 | .00 | .00 | .00 |
| Government Share | .00 | .00 | .00 | .00 | .00 |
| Capital Adequacy Ratio | .00 | .00 | .00 | .00 | .00 |
| EPS(Rs.) | .00 | .00 | .00 | .00 | .00 |
Quick Links
Aurobindo Pharma Ltd. Quick Links
Cash Flow Statement
Half Yearly Results
Capital Structure
Chairman's Speech
Company History
Locations
Dividends
Splits
Competitors
Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.
